secwatch.observer — SEC 8-K summary
======================================

Issuer:     CV Sciences, Inc. (CVSI)
CIK:        0001510964
Form:       8-K
Filed at:   2021-11-15T23:59:59+00:00
Accession:  0001510964-21-000065
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CV Sciences Q3 2021 revenue down 8% to $5.1M; cash drops to $1.7M
-----------------------------------------------------------------

- Revenue $5.1M vs $5.6M YoY (-8%); operating loss $3.0M vs $3.2M.
- Gross margin 46.2% (up 200 bps); retail stores 7,700 (up from 6,200).
- Cash balance $1.7M at quarter-end vs $4.5M at year-end.
- PPP loan of $2.9M forgiven; launched PlusCBD Reserve line.
- CEO cites CA AB 45 passage as favorable regulatory momentum for 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1510964/000151096421000065/0001510964-21-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1510964/000151096421000065/cvsi-20211115.htm
  HTML page:      https://secwatch.observer/filing/0001510964-21-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer